Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-04-06-Speech-3-354-500"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-04-06"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20110406.29.3-354-500"2
lpv:hasSubsequent	lp_eu:2011-04-06-Speech-3-359-0002
lpv:speaker	lp:Françoise Grossetête2
lpv:spokenAs	member; EPP (2009-07-14--2014-06-30)3 substitute; Delegation for relations with Australia and New Zealand (2009-09-16--2014-06-30)3 member; ENVI (2009-07-16--2012-01-18)3 substitute; ITRE (2009-07-16--2012-01-18)3 member; Delegation for relations with the countries of Central America (2009-09-16--2014-06-30)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3 unknown; Union pour un Mouvement Populaire (2009-07-14--2014-06-30)3
lpv:translated text	"Products for children such as formula milk must be able to benefit from claims if they have been scientifically validated by the European Food Safety Authority (EFSA) as in the case of docosahexaenoic acid (DHA), which contributes to the normal visual development of infants from six to 12 months of age. To prohibit all communication, even on recognised scientific effects, would considerably hinder research and innovation in this sector. It should also be remembered that, after six months, all women either do not wish, or are unable, to breast feed, and they must be able to benefit from preparations for infants for which health claims have been evaluated scientifically. It is not about claiming superiority for formula enriched with DHA over breast milk. It is not about that! Today, Parliament chose the path of reason by rejecting this resolution in favour of banning this claim and of heaping opprobrium on the work of the EFSA."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph